Images List Premium Download Classic

Diabetes

Diabetes-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Diabetes management systems, methods and apparatus for user reminders, pattern recognition, and interfaces
October 04, 2018 - N°20180286507

Systems, methods, and apparatus for diabetes management include a portable diabetes management system (dms) device. The dms device includes a processor, a data storage device, a touchscreen display, and wireless communications facilities.
Microenvironments for self-assembly of islet organoids from stem cells differentiation
October 04, 2018 - N°20180282699

Human pluripotent stem cells (hpscs) are promising cell source to produce therapeutic endocrine cells for diabetes treatment. A gel solution made by decellularized tissue-specific extracellular matrix (dpecm) significantly promotes three-dimensional (3d) islet-like organogenesis during induced hpsc differentiation into endocrine lineages.
Insulin analogs and use thereof
October 04, 2018 - N°20180282388

An insulin analog with an improved in vitro effect compared with native insulin, a nucleic acid encoding the same, an expression vector including the nucleic acid, a transformant introduced with the expression vector, a method of producing the insulin analog from the transformant, a pharmaceutical composition for treating diabetes containing the insulin analog as an active ingredient, and a method ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical formulations of desmopressin
October 04, 2018 - N°20180280469

Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material.
Use of l. reuteri for recovery of microbiota dysbiosis in early life
October 04, 2018 - N°20180280454

The invention concerns lactobacillus reuteri for use in the prevention or treatment of microbiota dysbiosis, in particular, decreased levels of actinobacteria and increased levels of proteobacteria, in young mammals and in the prevention or treatment of disorders associated therewith. The microbiota dysbiosis may have been cause by numerous factors including being born by caesarean section, exposure to antibiotics in utero ...
Methods and compositions for oral administration
October 04, 2018 - N°20180280292

This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral administration of a protein with an enzymatic activity, comprising orally administering same.. .
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibacterial and protective bacteriophage formulations and methods for making and using them
San Diego State University (sdsu) Foundation Dba San Diego State University Research Foundation
September 27, 2018 - N°20180273910

Provided are compositions and methods for treating, ameliorating and preventing infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor. Provided are compositions and methods used to treat, prevent or ameliorate an infection, for example, an infection in the gastrointestinal tract, or bowel.
Insulin secreting polypeptides
Mayo Foundation For Medical Education And Research
September 27, 2018 - N°20180273600

This document provides methods and materials related to insulin secreting polypeptides. For example, polypeptides having the ability to induce insulin secretion and methods and materials for using use such polypeptides to induce insulin secretion and to treat diabetes are provided..
Diabetes gene therapy
Ucl Business Plc
September 27, 2018 - N°20180272006

There is described a nucleic acid molecule comprising a nucleotide sequence encoding for a functional preproinsulin protein wherein the nucleotide sequence has at least 86% identity to the sequence of seq id no. 1.
Anti-net compounds for treating and preventing fibrosis and for facilitating wound healing
The Children's Medical Center Corporation
September 27, 2018 - N°20180271953

Embodiments of the technology described herein are based, in part, upon the discovery that netosis, the formation of neutrophil extracellular traps (nets) is increased in wounds, in organ fibrosis and in subjects with diabetes. Accordingly, methods for treating wounds, fibrosis and net associated complications in diabetes are provided.
Probiotic composition at least comprising bifidobacterium bifidum w23 and capable of controlling intestinal barrier function
Winclove Holding B.v.
September 27, 2018 - N°20180271919

The disclosure relates to the field of medicine and nutrition, more specifically, to the field of treatment and prevention of human disorders such as depression, rumination, aggression, migraine, autistic spectrum disorders (including autism and adhd), schizophrenia, chronic fatigue, kidney disorders, metabolic syndrome or diabetes type ii. The disclosure provides a pharmaceutical or food composition or a supplement comprising a multispecies ...
Aldose reductase inhibitors and uses thereof
The Trustee Of Columbia University In The City Of New York
September 27, 2018 - N°20180271865

The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment ...
Treatment for diabetes in patients inappropriate for metformin therapy
Boehringer Ingelheim International Gmbh
September 27, 2018 - N°20180271859

The present invention relates to the finding that certain dpp-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.. .
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Viral vectors for the treatment of diabetes
Universitat Autonoma De Barcelona
September 20, 2018 - N°20180265893

They are provided gene constructs comprising a nucleotide sequence encoding the insulin-like growth factor 1 (igf-1) of a mammal; and target sequences of a microrna of a tissue where the expression of igf-1 is wanted to be prevented, wherein the sequences (a) and (b) are operationally linked to a promoter of ubiquitous expression. Also provided are expression vectors comprising the gene ...
Glycated cd59 peptides, their preparation, and uses thereof
President And Fellows Of Harvard College
September 20, 2018 - N°20180265589

The present invention provides glycated amadori products of the cd59 peptide and fragments thereof to be used as tools and among methods for the diagnosis and prognosis of pre-diabetes and diabetes. Certain aspects of the invention include glycated amadori products of cd59 and fragments thereof to be used for the generation of antibodies and antibody fragments.
Vitamin d3 derivatives and pharmaceutical use thereof
National University Corporation Tokyo University Of Agriculture And Technology
September 20, 2018 - N°20180265463

The present invention relates to vitamin d3 derivatives of the following formula, wherein each symbol has the same meaning as defined herein, and pharmaceutical or medical use thereof for treating metabolic disease, liver disease, obesity, diabetes, cardiovascular disease, or cancer in a patient in need thereof.. .
Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for ...
Strongbridge Ireland Limited
September 20, 2018 - N°20180264073

The present invention provides compositions comprising water soluble peptides with poor solubility in isotonic solutions which exhibit enhanced bioavailability with reduced adverse effects including injection site reactions. Methods are also disclosed for using such compositions for the treatment of diseases including, but not limited to, cancer, type 2 diabetes, acromegaly, metabolic disorders, endocrine disorders, exocrine tumors, and hormone-related tumors.
Bromocriptine formulations
Veroscience Llc
September 20, 2018 - N°20180263978

The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes..
Methods of treating conditions related to the s1p1 receptor
Arena Pharmaceuticals, Inc.
September 20, 2018 - N°20180263958

Provided are methods of treatment of a sphingosine 1-phosphate subtype 1 (s1p1) receptor-associated disorder comprising prescribing and/or administering to an individual in need thereof a standard dose of (r)-2-(7-(4-cyclopentyl-3-(trifluoro-methyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid (compound 1), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, in an amount equivalent to about 1.5 ...
In vitro method for identifying a pregnancy related disease
September 13, 2018 - N°20180259534

The present invention is focused on an in vitro method for identifying or screening human subjects at risk of suffering from a pregnancy related disease, in particular from gestational diabetes mellitus or preeclampsia, departing from the level of expression or concentration of a series of biomarkers isolated from a minimally-invasive sample such as gingival crevicular fluid (gcf). Moreover, the method ...
Gip peptide analogues
September 13, 2018 - N°20180258152

Provided herein are glucose-dependent insulinotropic polypeptide (gip)-derived peptide analogues, for example gip(3-30), and their use as antagonists of the gip receptor and for treatment of disorders such as obesity, diabetes mellitus and insulin resistance.. .
Loading